{
  "title": "Special Episode, Part 2: Viruses, Variants and Vaccines",
  "description": "<p>Chief Cross-Asset Strategist Andrew Sheets continues his conversation with Biotech Equity Analyst Matt Harrison on COVID-19 variants and the future of the health care industry.</p>",
  "itunes:title": "Special Episode, Part 2: Viruses, Variants and Vaccines",
  "itunes:episodeType": "full",
  "itunes:episode": 393,
  "itunes:summary": "Chief Cross-Asset Strategist Andrew Sheets continues his conversation with Biotech Equity Analyst Matt Harrison on COVID-19 variants and the future of the health care industry.",
  "content:encoded": "<p>Chief Cross-Asset Strategist Andrew Sheets continues his conversation with Biotech Equity Analyst Matt Harrison on COVID-19 variants and the future of the health care industry.</p>",
  "guid": "gid://art19-episode-locator/V0/nR058On5d6ej3KUtjbT8J8PUCWIebKD-COj2F9e7Bjo",
  "pubDate": "Fri, 25 Jun 2021 22:26:47 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:10:09",
  "enclosure": ""
}